IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 10, Pages e111020
Publisher
Public Library of Science (PLoS)
Online
2014-10-25
DOI
10.1371/journal.pone.0111020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TLR2 and TLR9 Synergistically Control Herpes Simplex Virus Infection in the Brain
- (2014) L. N. Sorensen et al. JOURNAL OF IMMUNOLOGY
- Transgenic Parasites Stably Expressing Full-Length Plasmodium falciparum Circumsporozoite Protein as a Model for Vaccine Down-Selection in Mice Using Sterile Protection as an Endpoint
- (2013) Michael D. Porter et al. Clinical and Vaccine Immunology
- Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4+T Cell Immunity and Protection in Mice
- (2012) Kathrin Kastenmüller et al. INFECTION AND IMMUNITY
- Roles of the Amino Terminal Region and Repeat Region of the Plasmodium berghei Circumsporozoite Protein in Parasite Infectivity
- (2012) Cassandra Aldrich et al. PLoS One
- Protective CD8+ T lymphocytes in Primates Immunized with Malaria Sporozoites
- (2012) Walter R. Weiss et al. PLoS One
- Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine
- (2012) Stephen A. Kaba et al. PLoS One
- Adjuvant solution for pandemic influenza vaccine production
- (2012) C. H. Clegg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unexpected fold in the circumsporozoite protein target of malaria vaccines
- (2012) M. B. Doud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR-7 and -8 agonists as vaccine adjuvants
- (2011) Mark A Tomai et al. Expert Review of Vaccines
- Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets
- (2011) Kathrin Kastenmüller et al. JOURNAL OF CLINICAL INVESTIGATION
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- From the circumsporozoite protein to the RTS,S/AS candidate vaccine
- (2010) Joe Cohen et al. Human vaccines & immunotherapeutics
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Applying TLR Synergy in Immunotherapy: Implications in Cutaneous Leishmaniasis
- (2010) V. S. Raman et al. JOURNAL OF IMMUNOLOGY
- Structure of thePlasmodium falciparumCircumsporozoite Protein, a Leading Malaria Vaccine Candidate
- (2009) Matthew L. Plassmeyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
- (2009) Kent E. Kester et al. JOURNAL OF INFECTIOUS DISEASES
- Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
- (2009) Vasee S Moorthy et al. MALARIA JOURNAL
- Meta-analysis of immune epitope data for allPlasmodia: overview and applications for malarial immunobiology and vaccine-related issues
- (2009) K. VAUGHAN et al. PARASITE IMMUNOLOGY
- Enhanced Immunogenicity of Plasmodium falciparum Peptide Vaccines Using a Topical Adjuvant Containing a Potent Synthetic Toll-Like Receptor 7 Agonist, Imiquimod
- (2008) C. Othoro et al. INFECTION AND IMMUNITY
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
- Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
- (2008) Kent E. Kester et al. VACCINE
- Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
- (2008) Pierre Vandepapelière et al. VACCINE
- Effects of viral hemorrhagic septicemia virus (VHSV) on the rainbow trout (Oncorhynchus mykiss) monocyte cell line RTS-11
- (2007) Carolina Tafalla et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now